Loss of &bgr;-Catenin Promotes Chondrogenic Differentiation of Aortic Valve Interstitial Cells

Objective— The Wnt/&bgr;-catenin signaling pathway has been implicated in human heart valve disease and is required for early heart valve formation in mouse and zebrafish. However, the specific functions of Wnt/&bgr;-catenin signaling activity in heart valve maturation and maintenance in adults have not been determined previously. Approach and Results— Here, we show that Wnt/&bgr;-catenin signaling inhibits Sox9 nuclear localization and proteoglycan expression in cultured chicken embryo aortic valves. Loss of &bgr;-catenin in vivo in mice, using Periostin(Postn)Cre–mediated tissue-restricted loss of &bgr;-catenin (Ctnnb1) in valvular interstitial cells, leads to the formation of aberrant chondrogenic nodules and induction of chondrogenic gene expression in adult aortic valves. These nodular cells strongly express nuclear Sox9 and Sox9 downstream chondrogenic extracellular matrix genes, including Aggrecan, Col2a1, and Col10a1. Excessive chondrogenic proteoglycan accumulation and disruption of stratified extracellular matrix maintenance in the aortic valve leaflets are characteristics of myxomatous valve disease. Both in vitro and in vivo data demonstrate that the loss of Wnt/&bgr;-catenin signaling leads to increased nuclear expression of Sox9 concomitant with induced expression of chondrogenic extracellular matrix proteins. Conclusions— &bgr;-Catenin limits Sox9 nuclear localization and inhibits chondrogenic differentiation during valve development and in adult aortic valve homeostasis.

[1]  D. Chan,et al.  The chondrocytic journey in endochondral bone growth and skeletal dysplasia. , 2014, Birth defects research. Part C, Embryo today : reviews.

[2]  J. Defraigne,et al.  Emerging pathogenic mechanisms in human myxomatous mitral valve: lessons from past and novel data. , 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[3]  R. Norris,et al.  Mef2c Regulates Transcription of the Extracellular Matrix Protein Cartilage Link Protein 1 in the Developing Murine Heart , 2013, PloS one.

[4]  J. Ni,et al.  Comparison of the biological response of osteoblasts after tension and compression. , 2013, European journal of orthodontics.

[5]  E. Ortona,et al.  Human Myxomatous Mitral Valves Exhibit Focal Expression of Cartilage-related Proteins , 2013 .

[6]  C. Semsarian,et al.  Genetic Basis of Familial Valvular Heart Disease , 2012, Circulation. Cardiovascular genetics.

[7]  J. Bavaria,et al.  Human myxomatous mitral valve prolapse: Role of bone morphogenetic protein 4 in valvular interstitial cell activation , 2012, Journal of cellular physiology.

[8]  V. Lefebvre,et al.  Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes. , 2012, Developmental cell.

[9]  C. Lacerda,et al.  Signaling pathways in mitral valve degeneration. , 2012, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

[10]  K. Yutzey,et al.  Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease. , 2012, Journal of molecular and cellular cardiology.

[11]  V. Castronovo,et al.  Metallothionein-dependent up-regulation of TGF-β2 participates in the remodelling of the myxomatous mitral valve. , 2012, Cardiovascular research.

[12]  T. Guy,et al.  Mitral valve prolapse. , 2012, Annual review of medicine.

[13]  D. Chan,et al.  SOX9 Governs Differentiation Stage-Specific Gene Expression in Growth Plate Chondrocytes via Direct Concomitant Transactivation and Repression , 2011, PLoS genetics.

[14]  J. Lincoln,et al.  Sox9 Transcriptionally Represses Spp1 to Prevent Matrix Mineralization in Maturing Heart Valves and Chondrocytes , 2011, PloS one.

[15]  K. J. Grande-Allen,et al.  Calcific Aortic Valve Disease : Not Simply a Degenerative Process A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group , 2012 .

[16]  V. Lefebvre,et al.  Unraveling the transcriptional regulatory machinery in chondrogenesis , 2011, Journal of Bone and Mineral Metabolism.

[17]  A. Gotlieb,et al.  The response to valve injury. A paradigm to understand the pathogenesis of heart valve disease. , 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[18]  Takashi Nakamura,et al.  Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways , 2011, Development.

[19]  R. Hinton,et al.  Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves. , 2011, Journal of molecular and cellular cardiology.

[20]  R. Hinton,et al.  Heart valve structure and function in development and disease. , 2011, Annual review of physiology.

[21]  R. Hinton,et al.  Twist1 promotes heart valve cell proliferation and extracellular matrix gene expression during development in vivo and is expressed in human diseased aortic valves. , 2010, Developmental biology.

[22]  J. Lincoln,et al.  Reduced Sox9 Function Promotes Heart Valve Calcification Phenotypes In Vivo , 2010, Circulation Research.

[23]  Santanu Chakraborty,et al.  Wnt signaling in heart valve development and osteogenic gene induction. , 2010, Developmental biology.

[24]  Marc W. Kirschner,et al.  Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling , 2009, Nature.

[25]  K. Yutzey,et al.  Heart Valve Development: Regulatory Networks in Development and Disease , 2009, Circulation research.

[26]  A. Lassar,et al.  The Transcriptional Activity of Sox9 in Chondrocytes Is Regulated by RhoA Signaling and Actin Polymerization , 2009, Molecular and Cellular Biology.

[27]  K. Kadler,et al.  Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[28]  M. Taketo,et al.  Stabilization of beta-catenin in XY gonads causes male-to-female sex-reversal. , 2008, Human molecular genetics.

[29]  J. Bischoff,et al.  Opposing actions of Notch1 and VEGF in post-natal cardiac valve endothelial cells. , 2008, Biochemical and biophysical research communications.

[30]  Walter Birchmeier,et al.  Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. , 2008, Genes & development.

[31]  R. Hinton,et al.  Mouse heart valve structure and function: echocardiographic and morphometric analyses from the fetus through the aged adult. , 2008, American journal of physiology. Heart and circulatory physiology.

[32]  R. Markwald,et al.  Periostin Is Required for Maturation and Extracellular Matrix Stabilization of Noncardiomyocyte Lineages of the Heart , 2008, Circulation research.

[33]  Hongming Zhou,et al.  Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer. , 2007, Developmental biology.

[34]  R. Kist,et al.  Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. , 2007, Developmental biology.

[35]  J. Trochu,et al.  Mutations in the Gene Encoding Filamin A as a Cause for Familial Cardiac Valvular Dystrophy , 2006, Circulation.

[36]  Y. Kawakami,et al.  The role of TGFβs and Sox9 during limb chondrogenesis , 2006 .

[37]  K. Yutzey,et al.  Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. , 2006, Developmental biology.

[38]  R. Bonow,et al.  Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. , 2006, Journal of the American College of Cardiology.

[39]  K. Yutzey,et al.  BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. , 2006, Developmental biology.

[40]  J. I. Izpisúa Belmonte,et al.  The role of TGFbetas and Sox9 during limb chondrogenesis. , 2006, Current opinion in cell biology.

[41]  J. Marshall,et al.  New Locus for Autosomal Dominant Mitral Valve Prolapse on Chromosome 13: Clinical Insights From Genetic Studies , 2005, Circulation.

[42]  Xizhi Guo,et al.  Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. , 2005, Developmental cell.

[43]  Walter Birchmeier,et al.  Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. , 2005, Developmental cell.

[44]  F. Beier,et al.  RhoA/ROCK Signaling Regulates Sox9 Expression and Actin Organization during Chondrogenesis* , 2005, Journal of Biological Chemistry.

[45]  B. Griffin,et al.  Mitral valve prolapse , 2005, The Lancet.

[46]  S. Ikegawa,et al.  SOX9-dependent and -independent Transcriptional Regulation of Human Cartilage Link Protein* , 2004, Journal of Biological Chemistry.

[47]  E. Dejana,et al.  -Catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse , 2004 .

[48]  P. McCrea,et al.  Interactions between Sox9 and β-catenin control chondrocyte differentiation , 2004 .

[49]  P. McCrea,et al.  Interactions between Sox9 and beta-catenin control chondrocyte differentiation. , 2004, Genes & development.

[50]  P. Greengard,et al.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.

[51]  E. Cuppen,et al.  The Wnt/β-catenin pathway regulates cardiac valve formation , 2003, Nature.

[52]  A. Bookout,et al.  Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways , 2003, Nuclear receptor signaling.

[53]  Hans Clevers,et al.  Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors , 2002, Molecular and Cellular Biology.

[54]  A. McMahon,et al.  Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. , 2001, Development.

[55]  Philippe Soriano.  Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[56]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .